269 related articles for article (PubMed ID: 22616548)
1. Rehabilitating opioid regulation: a prescription for the FDA's next proposal of an opioid risk evaluation and mitigation strategy (REMS).
Homenko H
Health Matrix Clevel; 2012; 22(1):273-313. PubMed ID: 22616548
[No Abstract] [Full Text] [Related]
2. Issues and critiques of the forthcoming risk evaluation and mitigation strategy (REMS) for opioids in pain management.
Peppin JF; Coleman JJ; Kirsh KL
Issues Law Med; 2011; 27(2):91-119. PubMed ID: 22372206
[TBL] [Abstract][Full Text] [Related]
3. Opioid risk management: understanding FDA mandated risk evaluation and mitigation strategies (REMS).
Sloan PA
J Opioid Manag; 2009; 5(3):131-3. PubMed ID: 19662921
[No Abstract] [Full Text] [Related]
4. REMS; red tape, or a remedy for opioid abuse?
Porada S
J Fam Pract; 2011 Sep; 60(9 Suppl):S55-62. PubMed ID: 22442761
[No Abstract] [Full Text] [Related]
5. The FDA's Approach to the Prescription Opioid Problem.
Woodcock J; Throckmorton DC
Clin Pharmacol Ther; 2018 Jun; 103(6):954-955. PubMed ID: 29570773
[TBL] [Abstract][Full Text] [Related]
6. Extended-release/long-acting opioid REMS may fill the need for prescribers' appropriate use education.
Nicholson SC; Evanyo K; Salinas GD; Roepke N; Burton BS; Susalka D
J Opioid Manag; 2012; 8(4):212-6. PubMed ID: 22941848
[TBL] [Abstract][Full Text] [Related]
7. Curbing the opioid epidemic in the United States: the risk evaluation and mitigation strategy (REMS).
Nelson LS; Perrone J
JAMA; 2012 Aug; 308(5):457-8. PubMed ID: 22851109
[No Abstract] [Full Text] [Related]
8. Evolution of opioid risk management and review of the classwide REMS for extended-release/long-acting opioids.
Stanos S
Phys Sportsmed; 2012 Nov; 40(4):12-20. PubMed ID: 23306411
[TBL] [Abstract][Full Text] [Related]
9. The Food and Drug Administration opioid Risk Evaluation and Mitigation Strategy.
Lipman AG
J Pain Palliat Care Pharmacother; 2009; 23(3):219-21. PubMed ID: 19670017
[No Abstract] [Full Text] [Related]
10. Risk Evaluation and Mitigation Strategies (REMS) for extended-release and long-acting opioid analgesics: considerations for palliative care practice.
Gudin J
J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):136-43. PubMed ID: 22764852
[TBL] [Abstract][Full Text] [Related]
11. A Proactive Response to Prescription Opioid Abuse.
Califf RM; Woodcock J; Ostroff S
N Engl J Med; 2016 Apr; 374(15):1480-5. PubMed ID: 26845291
[No Abstract] [Full Text] [Related]
12. Foundations of opioid risk management.
Katz NP; Adams EH; Benneyan JC; Birnbaum HG; Budman SH; Buzzeo RW; Carr DB; Cicero TJ; Gourlay D; Inciardi JA; Joranson DE; Kesslick J; Lande SD
Clin J Pain; 2007 Feb; 23(2):103-18. PubMed ID: 17237659
[TBL] [Abstract][Full Text] [Related]
13. FDA actions to prevent prescription drug abuse.
Jeske AH
Tex Dent J; 2005 Jul; 122(7):634-45. PubMed ID: 16152888
[No Abstract] [Full Text] [Related]
14. Wanted: a public health approach to prescription opioid abuse and diversion.
Joranson DE; Gilson AM
Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):632-4. PubMed ID: 16862603
[No Abstract] [Full Text] [Related]
15. Shared risk evaluation mitigation strategy for all immediate-release transmucosal fentanyl dosage forms.
Food And Drug Administration, Public Health Service, U.S. Department Of Health And Human Services
J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):123-6. PubMed ID: 22764848
[TBL] [Abstract][Full Text] [Related]
16. Pain treatment, drug diversion, and the casualties of war.
Burgess F
Pain Med; 2006; 7(6):474-5. PubMed ID: 17112360
[No Abstract] [Full Text] [Related]
17. We can make opioids safer.
Lipman AG
J Pain Palliat Care Pharmacother; 2013 Jun; 27(2):112-3. PubMed ID: 23688516
[No Abstract] [Full Text] [Related]
18. FDA remodels REMS for opioid medications.
Stone A
ONS Connect; 2012 Sep; 27(9):18. PubMed ID: 23008909
[No Abstract] [Full Text] [Related]
19. Pain: the doctor's dilemma.
Phelps GL
Tenn Med; 2011 Apr; 104(4):7-8. PubMed ID: 21560903
[No Abstract] [Full Text] [Related]
20. Assessing the impact of the extended-release/long-acting opioid an-algesics risk evaluation and mitigation strategies on opioid prescrip-tion volume.
Divino V; Cepeda MS; Coplan P; Maziere JY; Yuan Y; Wade RL
J Opioid Manag; 2017; 13(3):157-168. PubMed ID: 28829517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
